Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease - PubMed (original) (raw)
Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease
M H Giaffer et al. Gut. 1992 May.
Abstract
Escherichia coli strains cultured from 74 patients with inflammatory bowel disease at different stages of disease activity (Crohn's disease (40), ulcerative colitis (34)) and 18 healthy controls were studied in relation to haemolysin and verotoxin production and enteroadherence. Disease activity was assessed by standard clinical and laboratory tests. Haemolytic E coli were isolated from 18% of patients with Crohn's disease, 24% with ulcerative colitis, and 11% of healthy controls. None of these differences was significant. No verotoxin producing strains were detected among the 216 E coli isolates examined but the extract from five strains (Crohn's (4), ulcerative colitis (1) produced a distinctive cytopathic effort on Vero cell monolayers which was later shown not to be due to verotoxin. The adhesion indices of E coli isolates cultured were: mean (SEM) 42.2 (6.4) for Crohn's disease, 43.3 (6.2) for ulcerative colitis, and 11.3 (2.0) for normal controls (p less than or equal to 0.0001). Adhesive E coli were isolated from 62% of patients with Crohn's disease and 68% with ulcerative colitis but from only 6% of normal controls (p less than or equal to 0.0002). Neither haemolysin production nor enteroadherence was dependent upon disease activity, disease location, sulphasalazine treatment, or previous intestinal resection. These results indicate that only enteroadherent E coli were frequently associated with inflammatory bowel disease; their relation to the pathogenesis of these conditions, however, remains uncertain.
Similar articles
- Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.
Burke DA, Axon AT. Burke DA, et al. BMJ. 1988 Jul 9;297(6641):102-4. doi: 10.1136/bmj.297.6641.102. BMJ. 1988. PMID: 3044496 Free PMC article. - High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.
Thomazini CM, Samegima DA, Rodrigues MA, Victoria CR, Rodrigues J. Thomazini CM, et al. Int J Med Microbiol. 2011 Aug;301(6):475-9. doi: 10.1016/j.ijmm.2011.04.015. Epub 2011 May 26. Int J Med Microbiol. 2011. PMID: 21616711 - [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
De La Fuente M, Chahuán I, Gutiérrez R, Díaz-Jiménez D, Olivares M, Vidal R, Simian D, Figueroa C, Quera R, Hermoso MA. De La Fuente M, et al. Rev Med Chil. 2017 Sep;145(9):1129-1136. doi: 10.4067/s0034-98872017000901129. Rev Med Chil. 2017. PMID: 29424399 Spanish. - Vero cytotoxin-producing strains of Escherichia coli.
Smith HR, Scotland SM. Smith HR, et al. J Med Microbiol. 1988 Jun;26(2):77-85. doi: 10.1099/00222615-26-2-77. J Med Microbiol. 1988. PMID: 3290494 Review. No abstract available. - Toxigenic Escherichia coli.
Chart H. Chart H. Symp Ser Soc Appl Microbiol. 1998;27:77S-86S. doi: 10.1046/j.1365-2672.1998.0840s177s.x. Symp Ser Soc Appl Microbiol. 1998. PMID: 9750364 Review. No abstract available.
Cited by
- IBD-what role do Proteobacteria play?
Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. Mukhopadhya I, et al. Nat Rev Gastroenterol Hepatol. 2012 Feb 21;9(4):219-30. doi: 10.1038/nrgastro.2012.14. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22349170 Review. - The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. Baldelli V, et al. Microorganisms. 2021 Mar 27;9(4):697. doi: 10.3390/microorganisms9040697. Microorganisms. 2021. PMID: 33801755 Free PMC article. Review. - Role of bacteria in the etiopathogenesis of inflammatory bowel disease.
Barnich N, Darfeuille-Michaud A. Barnich N, et al. World J Gastroenterol. 2007 Nov 14;13(42):5571-6. doi: 10.3748/wjg.v13.i42.5571. World J Gastroenterol. 2007. PMID: 17948930 Free PMC article. Review. - Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.
Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Sokol H, et al. J Clin Microbiol. 2006 Sep;44(9):3172-7. doi: 10.1128/JCM.02600-05. J Clin Microbiol. 2006. PMID: 16954244 Free PMC article.
References
- Br Med J. 1955 Oct 29;2(4947):1041-8 - PubMed
- BMJ. 1988 Jul 9;297(6641):102-4 - PubMed
- J Clin Pathol. 1987 Jul;40(7):782-6 - PubMed
- J Infect Dis. 1987 Mar;155(3):377-89 - PubMed
- Lancet. 1990 Apr 7;335(8693):816-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical